•   Home
• About Us
• Equity
• Derivatives
• Currency
• IPO
• Mutual Funds
• NRI Corner
• Depository
• Membership
•   Contact Us 

• Market Tracker
• Company Information
•   Corporate Actions
• News Analysis
• Other Markets

Profit and Loss

Ajanta Pharma Ltd Industry:  Pharmaceuticals - Indian - Formulations BSE Code ISIN Demat Book Value(R) NSE Symbol Div & Yield % Market Cap (Rs.Cr) P/E(TTM) EPS(TTM) Face Value(R) 532331 INE031B01049 273.2547485 AJANTPHARM 1.59 40410.94 48.61 66.55 2

Mar 2024 (Rs.Cr) Mar 2023 (Rs.Cr) Mar 2022 (Rs.Cr) Mar 2021 (Rs.Cr) Mar 2020 (Rs.Cr) Mar 2019 (Rs.Cr) INCOME :             Sales Turnover 3971.12 3411.27 3140.64 2718.59 2196.42 1772.62 Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00 Net Sales 3971.12 3411.27 3140.64 2718.59 2196.42 1772.62 Other Income 116.48 132.75 139.73 103.57 184.20 102.15 Stock Adjustments 22.17 21.99 56.60 74.60 -9.02 67.38 Total Income 4109.77 3566.01 3336.97 2896.76 2371.60 1942.15 EXPENDITURE :             Raw Materials 1101.59 1027.40 889.16 804.68 654.95 459.50 Power & Fuel Cost 66.44 65.53 54.09 43.42 38.56 33.77 Employee Cost 834.16 720.41 585.87 498.11 437.82 389.37 Other Manufacturing Expenses 168.11 185.50 169.95 119.25 124.80 121.50 Selling & Administrative Expenses 587.88 602.95 512.46 324.31 308.60 264.98 Miscellaneous Expenses 115.68 132.19 94.82 86.51 93.81 89.67 Less : Pre-operative Expenses Capitalised 0.00 0.00 0.00 0.00 0.00 0.00 Total Expenditure 2873.86 2733.98 2306.35 1876.28 1658.54 1358.79 Operating Profit 1235.91 832.03 1030.62 1020.48 713.06 583.36 Interest 6.80 5.23 9.12 6.90 9.10 0.41 Gross Profit 1229.11 826.80 1021.50 1013.58 703.96 582.95 Depreciation 132.16 126.95 120.96 111.49 91.29 69.90 Profit Before Tax 1096.95 699.85 900.54 902.09 612.67 513.05 Tax 280.56 141.08 171.17 216.68 168.09 108.66 Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00 Deferred Tax 9.15 0.05 9.51 9.77 3.45 12.63 Reported Net Profit 807.24 558.72 719.86 675.64 441.13 391.76 Extraordinary Items 11.11 12.87 -0.62 2.91 -2.89 -0.18 Adjusted Net Profit 796.13 545.85 720.48 672.73 444.02 391.94 Adjustment below Net Profit -0.92 -74.72 -68.50 -32.42 -3.85 -0.99 P & L Balance brought forward 3089.29 2694.98 2125.83 1565.51 1244.15 932.97 Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00 Appropriations 642.17 89.69 82.21 82.90 115.93 79.59 P & L Balance carried down 3253.44 3089.29 2694.98 2125.83 1565.50 1244.15 Dividend 642.17 89.69 82.21 82.90 113.44 79.22 Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00 Equity Dividend % 2550.00 350.00 475.00 475.00 650.00 450.00 Dividend Per Share(Rs) 51.00 7.00 9.50 9.50 13.00 9.00 Earnings Per Share-Unit Curr 63.89 44.22 83.85 77.70 50.30 44.67 Earnings Per Share(Adj)-Unit Curr 63.89 44.22 55.90 51.80 33.53 29.78 Book Value-Unit Curr 270.17 256.94 369.15 331.80 280.65 244.25 Book Value(Adj)-Unit Curr 270.17 256.94 246.10 221.20 187.10 162.83